Sales rise 5.57% to Rs 59.49 crore
Net profit of Jagsonpal Pharmaceuticals rose 82.29% to Rs 7.31 crore in the quarter ended September 2021 as against Rs 4.01 crore during the previous quarter ended September 2020. Sales rose 5.57% to Rs 59.49 crore in the quarter ended September 2021 as against Rs 56.35 crore during the previous quarter ended September 2020. ParticularsQuarter EndedSep. 2021Sep. 2020% Var.Sales59.4956.35 6 OPM %17.308.59 -PBDT10.515.13 105 PBT10.284.86 112 NP7.314.01 82Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
